+検索条件
-Structure paper
| タイトル | Structural basis of disease mutation and substrate recognition by the human SLC2A9 transporter. |
|---|---|
| ジャーナル・号・ページ | Proc Natl Acad Sci U S A, Vol. 122, Issue 7, Page e2418282122, Year 2025 |
| 掲載日 | 2025年2月18日 |
著者 | Nitesh Kumar Khandelwal / Meghna Gupta / Paras Kumar / Sree Ganesh Balasubramani / Ignacia Echeverria / Robert M Stroud / ![]() |
| PubMed 要旨 | Urate provides ~50% of the reducing potential in human and primate plasma which is key to detoxifying reactive oxygen by-products of cellular metabolism. Urate is the endpoint of purine metabolism in ...Urate provides ~50% of the reducing potential in human and primate plasma which is key to detoxifying reactive oxygen by-products of cellular metabolism. Urate is the endpoint of purine metabolism in primates, and its concentration in plasma is a balance between excretion from kidney and intestine, and subsequent reabsorption in and through cells of kidney proximal tubules to maintain a regulated concentration in plasma. SLC2A9 is the primary transporter that returns urate from the basolateral side of kidney tubule cells back to plasma. A shorter splice variant of SLC2A9 is directed to the apical surface where several transporters recapture urate from the tubule back into cells. Too high a concentration in plasma causes hyperuricemia, is linked to gout, and favors kidney stone formation. To understand the molecular basis of uric acid transport and the role of disease-causing mutations in SLC2A9, we determined structures of human SLC2A9 in its apo form, and its urate-bound form by cryo-EM, at resolution of 3.3 Å and 4.1 Å respectively. Both structures are captured in an inward open conformation. Using the inward-facing structure as a template we modeled the outward-facing conformation to understand the alternating access mechanism. Alternative salt bridge pairs on the cytoplasmic side suggest a mechanism that can balance the energetics of the inward open and outward open states. The location of disease-causing mutants suggests their role in impacting function. Our structures elucidate the molecular basis for urate selectivity and transport and provide a platform for future structure-based drug discovery aimed at reducing plasma urate levels in diseases of hyperuricemia and gout. |
リンク | Proc Natl Acad Sci U S A / PubMed:39937868 / PubMed Central |
| 手法 | EM (単粒子) |
| 解像度 | 3.37 - 4.15 Å |
| 構造データ | EMDB-45406, PDB-9cax: EMDB-45421, PDB-9cbb: |
| 化合物 | ![]() ChemComp-URC: |
| 由来 |
|
キーワード | MEMBRANE PROTEIN / Transporter |
ムービー
コントローラー
構造ビューア
万見文献について



著者
リンク




Homo sapiens (Human) (ヒト)
キーワード